Successful treatment of invasive carbapenemase-producing Enterobacteriaceae infections in children using carbapenem-aminoglycoside combination therapy: A case series.

Infection, Disease & Health
Phoebe C M WilliamsBrendan J McMullan

Abstract

Multidrug-resistant infections present a treatment challenge for pediatric clinicians and these infections have been associated with increased morbidity and mortality. There are very limited published data to support safe and effective treatment regimens for carbapenemase-producing Enterobacteriaceae (CPE) infections, particularly in children. We report the successful treatment of three children with invasive CPE infections using a combination of extended-infusion meropenem and amikacin.

Related Concepts

Related Feeds

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Related Papers

Enfermedades infecciosas y microbiología clínica
Jesús Rodríguez-BañoJosé Antonio Martínez
Enfermedades infecciosas y microbiología clínica
Ismael Mora-GuzmánElena Martín-Pérez
Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America
Sara ColomboPier-Angelo Tovo
Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America
Adriana JimenezMary Jo Trepka
© 2021 Meta ULC. All rights reserved